Systemic remifentanil for labor analgesia.
There is a need for safe, effective, and easy-to-administer systemic analgesia that ideally has rapid onset and offset, matches the time course of uterine contractions, and does not compromise the fetus. Although neuraxial blockade is the "gold standard" for labor analgesia, systemic analgesia is useful in those cases in which neuraxial analgesia is contraindicated, refused or simply not needed by the parturient, or when skilled anesthesia providers are not available. Because of its unique pharmacologic properties, remifentanil has been investigated, and is used clinically, to provide IV labor analgesia. In this focused review, we summarize the efficacy of remifentanil as a labor analgesic and review the current literature regarding its dose, mode of delivery, safety for the mother and fetus/neonate, as well as the scope for future research.
Hinova
Anelia
A
Department of Anesthesia, St. Mary's Hospital, UK.
Fernando
Roshan
R
D016362:Analgesia, Obstetrical / Q000009:adverse effects / Q000379:methods*; D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D048949:Labor Pain / Q000188:drug therapy*; D010147:Pain Measurement; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D011247:Pregnancy; D000077208:Remifentanil; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D010880:Piperidines; D000077208:Remifentanil